DE602007008581D1 - Verfahren zur bestimmung des antigengehalts in einer probe unter verwendung eines immunhistochemischen doppelnachweises - Google Patents

Verfahren zur bestimmung des antigengehalts in einer probe unter verwendung eines immunhistochemischen doppelnachweises

Info

Publication number
DE602007008581D1
DE602007008581D1 DE602007008581T DE602007008581T DE602007008581D1 DE 602007008581 D1 DE602007008581 D1 DE 602007008581D1 DE 602007008581 T DE602007008581 T DE 602007008581T DE 602007008581 T DE602007008581 T DE 602007008581T DE 602007008581 D1 DE602007008581 D1 DE 602007008581D1
Authority
DE
Germany
Prior art keywords
sample
antigen content
determining
double detection
immunohistochemical double
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007008581T
Other languages
English (en)
Inventor
Pierre Moulin
Yves Guiot
Jacques Rahier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CLINIQUES UNIVERSITAIRES SAINT
Universite Catholique de Louvain UCL
Original Assignee
CLINIQUES UNIVERSITAIRES SAINT
Universite Catholique de Louvain UCL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CLINIQUES UNIVERSITAIRES SAINT, Universite Catholique de Louvain UCL filed Critical CLINIQUES UNIVERSITAIRES SAINT
Publication of DE602007008581D1 publication Critical patent/DE602007008581D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/583—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with non-fluorescent dye label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Image Processing (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
DE602007008581T 2006-08-25 2007-08-24 Verfahren zur bestimmung des antigengehalts in einer probe unter verwendung eines immunhistochemischen doppelnachweises Active DE602007008581D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP2006008376 2006-08-25
PCT/EP2007/058810 WO2008023055A1 (en) 2006-08-25 2007-08-24 Method and kit for determining antigen content in a sample using double immunohistochemical detection

Publications (1)

Publication Number Publication Date
DE602007008581D1 true DE602007008581D1 (de) 2010-09-30

Family

ID=37179070

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007008581T Active DE602007008581D1 (de) 2006-08-25 2007-08-24 Verfahren zur bestimmung des antigengehalts in einer probe unter verwendung eines immunhistochemischen doppelnachweises

Country Status (5)

Country Link
US (1) US20090191573A1 (de)
EP (1) EP2059814B1 (de)
AT (1) ATE478339T1 (de)
DE (1) DE602007008581D1 (de)
WO (1) WO2008023055A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10928398B2 (en) * 2008-12-17 2021-02-23 Cornell University Method for double staining colocalized nuclear-markers in histological lymphoid or bone marrow tissue sample
US8233389B2 (en) * 2009-08-19 2012-07-31 Mitsubishi Electric Research Laboratories, Inc. Method and protocol for congestion control in a vehicular network
SG11201406104QA (en) 2012-03-30 2014-10-30 Clarient Diagnostic Services Inc Methods for generating an image of a biological sample
IT202000030365A1 (it) * 2020-12-10 2022-06-10 Addax Biosciences S R L Metodo di determinazione immunoistochimica quantitativa di antigeni

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6165734A (en) * 1995-12-12 2000-12-26 Applied Spectral Imaging Ltd. In-situ method of analyzing cells
JP3524401B2 (ja) * 1998-09-16 2004-05-10 株式会社ニチレイ 酵素抗体複合体およびその製造方法

Also Published As

Publication number Publication date
WO2008023055A1 (en) 2008-02-28
EP2059814B1 (de) 2010-08-18
US20090191573A1 (en) 2009-07-30
EP2059814A1 (de) 2009-05-20
ATE478339T1 (de) 2010-09-15

Similar Documents

Publication Publication Date Title
SG10201408392PA (en) Methods of determining patient response by measurement of her-3
WO2006026020A3 (en) Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin
MX2007014815A (es) Metodos de inmunoanalisis mejorados.
BRPI0707645B8 (pt) métodos in vitro para detecção de câncer em um indivíduo e para avaliação de prognóstico de um indivíduo tendo, ou suspeito de ter, câncer ovariano
ATE503846T1 (de) Verfahren zur diagnose eines ovarialkarzinoms
ATE426175T1 (de) Verfahren zur standardisierung von gerinnungstesten
WO2011079938A3 (en) System and method for determining the concentration of an analyte in a sample fluid
KR100711046B1 (ko) 대장암에 대한 마커로서의 니코틴아미드ｎ―메틸트랜스퍼라아제의 용도
WO2007024735A3 (en) Method and antibodies for detecting nitrofuran
WO2005103698A3 (en) Methods and antibodies for nitrofuran detection
DE60128249D1 (de) Verfahren zur diagnose von immunologischer lebensmittelsensitivität
WO2010046443A3 (en) Methods for detection and diagnosis of a bone or cartilage disorder
ATE471512T1 (de) Verwendung des proteins s100a 12 als marker für kolorektalkarzinom
ATE516505T1 (de) Verfahren zur zerstörungsfreien erfassung einer drehbewegung auf der oberfläche eines prüflings; vorrichtung hierzu sowie prüfeinheit
CA2701341A1 (en) Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
WO2005124356A3 (en) Use of protein cbp2 as a marker for colorectal cancer
DE602007008581D1 (de) Verfahren zur bestimmung des antigengehalts in einer probe unter verwendung eines immunhistochemischen doppelnachweises
ATE364210T1 (de) Verfahren zur bestimmung der position von geräten einer gefahrenmeldeanlage
ATE492815T1 (de) Diagnostik-biomolekül(e)
FR2894675B1 (fr) Distinction des meningites bacteriennes et virales
WO2006066917A3 (en) Use of asc as a marker for colorectal cancer
ATE468535T1 (de) Verwendung von nnmt als marker für lungenkrebs
SE0602683L (sv) Diagnostisk metod
DE602005010548D1 (de) Verbessertes verfahren zur diagnose des akuten koronarsyndroms
DE602007011886D1 (de) Diagnostisches Verfahren zum Nachweis von Helicobacter pylori